ASX - By Stock
|
ATH |
Re:
Alpha-synuclein induced synucleinopathies and NBIA's
|
|
Domy
|
10 |
2.9K |
3 |
26/04/24 |
26/04/24 |
ASX - By Stock
|
10
|
2.9K
|
3
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Alterity Parkinson's and MSA Data Featured at AAN Meeting
|
|
Domy
|
22 |
5.5K |
6 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
22
|
5.5K
|
6
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Alterity to Present New ATH434 Data at Orphan Drug Congress
|
|
Domy
|
29 |
7.7K |
4 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
29
|
7.7K
|
4
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Alterity to Present New ATH434 Data at Orphan Drug Congress
|
|
Domy
|
29 |
7.7K |
6 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
29
|
7.7K
|
6
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Alterity Therapeutics Raises $3.25 M AUD in Placement
|
|
Domy
|
8 |
2.7K |
1 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
8
|
2.7K
|
1
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Trading Halt
|
|
Domy
|
26 |
7.9K |
1 |
23/02/24 |
23/02/24 |
ASX - By Stock
|
26
|
7.9K
|
1
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Trading Halt
|
|
Domy
|
26 |
7.9K |
1 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
26
|
7.9K
|
1
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Alterity to Present New Data at the AAN 2024 Annual Meeting
|
|
Domy
|
12 |
4.0K |
6 |
20/02/24 |
20/02/24 |
ASX - By Stock
|
12
|
4.0K
|
6
|
|
ASX - By Stock
|
ATH |
Re:
Finally Moving North
|
|
Domy
|
15 |
3.6K |
8 |
08/02/24 |
08/02/24 |
ASX - By Stock
|
15
|
3.6K
|
8
|
|
ASX - By Stock
|
PEN |
Re:
Ann: A$10m SPP Closes Substantially Oversubscribed
|
|
Domy
|
172 |
62K |
3 |
05/02/24 |
05/02/24 |
ASX - By Stock
|
172
|
62K
|
3
|
|
ASX - By Stock
|
PEN |
Re:
Ann: A$10m SPP Closes Substantially Oversubscribed
|
|
Domy
|
172 |
62K |
4 |
05/02/24 |
05/02/24 |
ASX - By Stock
|
172
|
62K
|
4
|
|
ASX - By Stock
|
ATH |
Re:
Biogen to halt sales and development of controversial Alzheimer's drug Aduhelm
|
|
Domy
|
1 |
528 |
4 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
1
|
528
|
4
|
|
ASX - By Stock
|
ATH |
Re:
Levodopa rescues retinal function in PD model by Finkelstein et al
|
|
Domy
|
3 |
1.2K |
7 |
30/01/24 |
30/01/24 |
ASX - By Stock
|
3
|
1.2K
|
7
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Shareholder Letter Reports Pipeline Advances and Milestones
|
|
Domy
|
13 |
4.0K |
3 |
22/01/24 |
22/01/24 |
ASX - By Stock
|
13
|
4.0K
|
3
|
|
ASX - By Stock
|
ATH Medicine |
Re:
Broker Data/Price Chart - ATH
|
|
Domy
|
18 |
6.5K |
3 |
14/01/24 |
14/01/24 |
ASX - By Stock
|
18
|
6.5K
|
3
|
|
ASX - By Stock
|
ATH |
Re:
Ann: SPP with Continued Support from Institutional Shareholders
|
|
Domy
|
1 |
644 |
6 |
11/01/24 |
11/01/24 |
ASX - By Stock
|
1
|
644
|
6
|
|
ASX - By Stock
|
ATH |
Re:
Peter Marks in FDA: accelerated approvals for rare diseases
|
|
Domy
|
6 |
2.4K |
2 |
06/12/23 |
06/12/23 |
ASX - By Stock
|
6
|
2.4K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Positive Efficacy Data for ATH434 in a Primate Model of PD
|
|
Domy
|
32 |
10K |
4 |
05/12/23 |
05/12/23 |
ASX - By Stock
|
32
|
10K
|
4
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Positive Efficacy Data for ATH434 in a Primate Model of PD
|
|
Domy
|
32 |
10K |
0 |
04/12/23 |
04/12/23 |
ASX - By Stock
|
32
|
10K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Positive Efficacy Data for ATH434 in a Primate Model of PD
|
|
Domy
|
32 |
10K |
2 |
04/12/23 |
04/12/23 |
ASX - By Stock
|
32
|
10K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Positive Efficacy Data for ATH434 in a Primate Model of PD
|
|
Domy
|
32 |
10K |
2 |
04/12/23 |
04/12/23 |
ASX - By Stock
|
32
|
10K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Alterity Therapeutics Raises $4.8M AUD in Placement
|
|
Domy
|
23 |
8.6K |
3 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
23
|
8.6K
|
3
|
|
ASX - By Stock
|
ATH |
Re:
Ann: ATH presents Novel Biomarker Data for Evaluation of MSA
|
|
Domy
|
3 |
1.0K |
1 |
27/11/23 |
27/11/23 |
ASX - By Stock
|
3
|
1.0K
|
1
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Alterity Therapeutics Raises $4.8M AUD in Placement
|
|
Domy
|
23 |
8.6K |
0 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
23
|
8.6K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Trading Halt
|
|
Domy
|
2 |
796 |
0 |
20/11/23 |
20/11/23 |
ASX - By Stock
|
2
|
796
|
0
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Trading Halt
|
|
Domy
|
2 |
796 |
0 |
20/11/23 |
20/11/23 |
ASX - By Stock
|
2
|
796
|
0
|
|
ASX - By Stock
|
ATH |
Re:
Ann: New Data Demonstrating Novel Mechanisms of ATH434
|
|
Domy
|
4 |
1.2K |
3 |
16/11/23 |
16/11/23 |
ASX - By Stock
|
4
|
1.2K
|
3
|
|
ASX - By Stock
|
ATH |
Re:
Ann: ATH completes enrolment in ATH434-201 Phase 2 clinical trial
|
|
Domy
|
8 |
2.3K |
3 |
09/11/23 |
09/11/23 |
ASX - By Stock
|
8
|
2.3K
|
3
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Domy
|
5 |
1.5K |
2 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
5
|
1.5K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
Domy
|
5 |
1.5K |
8 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
5
|
1.5K
|
8
|
|
ASX - By Stock
|
SPN |
Re:
Ann: Sodium Ion Battery Project Receives AEA Grant
|
|
Domy
|
3 |
805 |
3 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
3
|
805
|
3
|
|
ASX - By Stock
|
SPN |
Re:
Ann: Sparc Hydrogen Receives Australian Government Grant
|
|
Domy
|
18 |
4.0K |
0 |
20/10/23 |
20/10/23 |
ASX - By Stock
|
18
|
4.0K
|
0
|
|
ASX - By Stock
|
SPN |
Re:
Ann: Sparc Hydrogen Receives Australian Government Grant
|
|
Domy
|
18 |
4.0K |
5 |
19/10/23 |
19/10/23 |
ASX - By Stock
|
18
|
4.0K
|
5
|
|
ASX - By Stock
|
SPN |
Re:
Ann: Sparc Hydrogen Receives Australian Government Grant
|
|
Domy
|
18 |
4.0K |
3 |
19/10/23 |
19/10/23 |
ASX - By Stock
|
18
|
4.0K
|
3
|
|
ASX - By Stock
|
SPN |
Re:
Ann: Sparc Hydrogen Receives Australian Government Grant
|
|
Domy
|
18 |
4.0K |
0 |
19/10/23 |
19/10/23 |
ASX - By Stock
|
18
|
4.0K
|
0
|
|
ASX - By Stock
|
ATH |
Re:
Sidney up 14%, NY down 17%
|
|
Domy
|
4 |
1.3K |
7 |
17/10/23 |
17/10/23 |
ASX - By Stock
|
4
|
1.3K
|
7
|
|
ASX - By Stock
|
SPN |
Re:
Ann: Sparc Hydrogen Commences Prototype Testing at CSIRO
|
|
Domy
|
19 |
5.1K |
1 |
16/10/23 |
16/10/23 |
ASX - By Stock
|
19
|
5.1K
|
1
|
|
ASX - By Stock
|
SPN |
Re:
Ann: Sparc Hydrogen Commences Prototype Testing at CSIRO
|
|
Domy
|
19 |
5.1K |
2 |
16/10/23 |
16/10/23 |
ASX - By Stock
|
19
|
5.1K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
Iron overload makes you biologically older
|
|
Domy
|
2 |
690 |
4 |
10/10/23 |
10/10/23 |
ASX - By Stock
|
2
|
690
|
4
|
|
ASX - By Stock
|
BIT |
Re:
$30 Billion Deal
|
|
Domy
|
5.0K |
1.3M |
0 |
09/10/23 |
09/10/23 |
ASX - By Stock
|
5.0K
|
1.3M
|
0
|
|
ASX - By Stock
|
BIT |
Re:
$30 Billion Deal
|
|
Domy
|
5.0K |
1.3M |
10 |
06/10/23 |
06/10/23 |
ASX - By Stock
|
5.0K
|
1.3M
|
10
|
|
ASX - By Stock
|
BIT |
Re:
$30 Billion Deal
|
|
Domy
|
5.0K |
1.3M |
0 |
06/10/23 |
06/10/23 |
ASX - By Stock
|
5.0K
|
1.3M
|
0
|
|
ASX - By Stock
|
BIT |
Re:
$30 Billion Deal
|
|
Domy
|
5.0K |
1.3M |
1 |
06/10/23 |
06/10/23 |
ASX - By Stock
|
5.0K
|
1.3M
|
1
|
|
ASX - By Stock
|
SYA |
Re:
General Discussion Topics
|
|
Domy
|
137K |
52M |
2 |
11/09/23 |
11/09/23 |
ASX - By Stock
|
137K
|
52M
|
2
|
|
ASX - By Stock
|
SPN |
Re:
Live-stream of presentation
|
|
Domy
|
23 |
7.3K |
1 |
05/09/23 |
05/09/23 |
ASX - By Stock
|
23
|
7.3K
|
1
|
|
ASX - By Stock
|
ACB |
Re:
Ann: ACAP ENERGY LOTUS RESOURCES MERGER
|
|
Domy
|
58 |
28K |
1 |
04/09/23 |
04/09/23 |
ASX - By Stock
|
58
|
28K
|
1
|
|
ASX - By Stock
|
SYA |
Re:
General Discussion Topics
|
|
Domy
|
137K |
52M |
1 |
28/08/23 |
28/08/23 |
ASX - By Stock
|
137K
|
52M
|
1
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Alterity Granted New Composition of Matter Patent in Europe
|
|
Domy
|
14 |
4.3K |
1 |
27/08/23 |
27/08/23 |
ASX - By Stock
|
14
|
4.3K
|
1
|
|
ASX - By Stock
|
LLI |
Re:
Ann: Inaugural Field Program Commenced at Trieste Lithium Project
|
|
Domy
|
9 |
3.1K |
15 |
08/08/23 |
08/08/23 |
ASX - By Stock
|
9
|
3.1K
|
15
|
|
ASX - By Stock
|
LLI |
Re:
Ann: Exploration Underway at Hidden Lake Lithium
|
|
Domy
|
96 |
30K |
0 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
96
|
30K
|
0
|
|